Sponsors (4)
The bill strengthens U.S. tools to disrupt PRC‑linked synthetic narcotics networks and aids enforcement, but its broad definitions and lower legal standards substantially increase compliance costs, legal uncertainty, risks to legitimate trade and remittances, and the potential for diplomatic blowback.
People in the U.S. and around the world: stronger and retained sanctions and asset‑blocking tools that disrupt illicit synthetic narcotics supply chains and make it harder for traffickers to operate.
Banks, Treasury, and U.S. regulators: clearer authority to freeze or block property and restrict correspondent relationships, giving financial institutions tools to stop funds for designated illicit actors and increase the practical effectiveness of sanctions.
Federal law enforcement and public health regulators: clearer definitions of 'illicit synthetic narcotics' (including APIs and listed chemicals) that help target investigations and interdiction of drug supply‑chain actors.
Banks, businesses, and individuals doing cross‑border commerce: very broad definitions (including subsidiaries, affiliates, 'for or on behalf of', and a lowered 'should‑have‑known' standard) create legal uncertainty and risk exposing parties with indirect or negligent links to severe penalties.
U.S. banks, financial institutions and their customers: increased compliance costs, reporting burdens, and elevated legal risk from expanded blocking/reporting obligations and broad covered‑conduct definitions.
U.S. businesses, consumers, and overseas correspondents: restrictions on correspondent accounts and foreign banks could disrupt international payments, raise costs or delays for cross‑border transactions, and harm remittances and financial inclusion for vulnerable customers.
Based on analysis of 5 sections of legislative text.
Codifies existing fentanyl sanctions and creates new IEEPA-based blocking sanctions and bank-account restrictions for PRC-linked actors involved in illicit synthetic narcotics.
Official title: To authorize sanctions relating to the production and distribution of illicit synthetic narcotics by the People's Republic of China.
Introduced August 24, 2026 by Jake Auchincloss · Last progress August 24, 2026
Codifies existing U.S. sanctions tied to global illicit drug trafficking and creates a new statutory sanctions authority using the International Emergency Economic Powers Act (IEEPA) to block property and transactions of foreign persons tied to the production, distribution, or facilitation of illicit synthetic narcotics connected to the People’s Republic of China (including Hong Kong and Macau). It also authorizes the Treasury, after consulting State, to restrict or condition U.S. correspondent and payable-through accounts for foreign financial institutions that knowingly facilitate transactions for designated persons. The bill applies civil and criminal IEEPA penalties for violations, allows the President to waive sanctions for national security reasons in renewable 180-day increments, and requires consideration of information from congressional leaders and credible foreign/NGO sources before imposing sanctions. Definitions and procedural rules are provided, and many new IEEPA authorities become available 180 days after enactment while the existing Executive Order sanctions are preserved as law immediately upon enactment.